Is plasma bio-ADM associated with clinical signs of congestion in patients with new-onset and worsening heart failure?
Bio-ADM is a potential biomarker of congestion that may be useful to guide decongestive therapy in heart failure patients.
Plasma bio-ADM in patients with new-onset and worsening HF is associated with more severe HF and more oedema, orthopnoea, hepatomegaly and jugular venous pressure. We therefore postulate bio-ADM as a congestion marker, which might become useful to guide decongestive therapy.
Maaten et al. (Wed,) studied this question.